| Status: | Phase 3 |
| Entry Type: | Antibody |
| UNII: | 7OSV6M6T4D |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL6068570 |
| FDA SRS | 7OSV6M6T4D |
CONTENTS
| Status: | Phase 3 |
| Entry Type: | Antibody |
| UNII: | 7OSV6M6T4D |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL6068570 |
| FDA SRS | 7OSV6M6T4D |